Premium
AACR meeting highlights new findings on drug resistance, targeted therapies
Author(s) -
Printz Carrie
Publication year - 2013
Publication title -
cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.052
H-Index - 304
eISSN - 1097-0142
pISSN - 0008-543X
DOI - 10.1002/cncr.28337
Subject(s) - medicine , vemurafenib , cancer , rna interference , clinical trial , cancer research , trametinib , drug resistance , kinase , oncology , gene , rna , genetics , mapk/erk pathway , metastatic melanoma , biology